IRIS Accounts Production v23.1.5.20 07099361 Board of Directors 1.7.22 30.6.23 30.6.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070993612022-06-30070993612023-06-30070993612022-07-012023-06-30070993612021-06-30070993612021-07-012022-06-30070993612022-06-3007099361ns15:EnglandWales2022-07-012023-06-3007099361ns14:PoundSterling2022-07-012023-06-3007099361ns10:Director12022-07-012023-06-3007099361ns10:PrivateLimitedCompanyLtd2022-07-012023-06-3007099361ns10:SmallEntities2022-07-012023-06-3007099361ns10:AuditExempt-NoAccountantsReport2022-07-012023-06-3007099361ns10:SmallCompaniesRegimeForDirectorsReport2022-07-012023-06-3007099361ns10:SmallCompaniesRegimeForAccounts2022-07-012023-06-3007099361ns10:FullAccounts2022-07-012023-06-3007099361ns10:OrdinaryShareClass12022-07-012023-06-3007099361ns10:Director22022-07-012023-06-3007099361ns10:RegisteredOffice2022-07-012023-06-3007099361ns5:CurrentFinancialInstruments2023-06-3007099361ns5:CurrentFinancialInstruments2022-06-3007099361ns5:Non-currentFinancialInstruments2023-06-3007099361ns5:Non-currentFinancialInstruments2022-06-3007099361ns5:ShareCapital2023-06-3007099361ns5:ShareCapital2022-06-3007099361ns5:RetainedEarningsAccumulatedLosses2023-06-3007099361ns5:RetainedEarningsAccumulatedLosses2022-06-3007099361ns5:PlantMachinery2022-07-012023-06-3007099361ns5:FurnitureFittings2022-07-012023-06-3007099361ns5:PlantMachinery2022-06-3007099361ns5:FurnitureFittings2022-06-3007099361ns5:PlantMachinery2023-06-3007099361ns5:FurnitureFittings2023-06-3007099361ns5:PlantMachinery2022-06-3007099361ns5:FurnitureFittings2022-06-3007099361ns10:OrdinaryShareClass12023-06-30
REGISTERED NUMBER: 07099361 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2023

for

Nanobiotech London Limited

Nanobiotech London Limited (Registered number: 07099361)






Contents of the Financial Statements
for the Year Ended 30 June 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Nanobiotech London Limited

Company Information
for the Year Ended 30 June 2023







DIRECTORS: Dr A Hussain
N Ljepojevic





REGISTERED OFFICE: Unit 3
Parkfields Industrial Estate
Culvert Place
London
SW11 5BA





REGISTERED NUMBER: 07099361 (England and Wales)





ACCOUNTANTS: Bennett and Company
Chartered Certified Accountants
The Coach House
Ealing Green
London
W5 5ER

Nanobiotech London Limited (Registered number: 07099361)

Balance Sheet
30 June 2023

30.6.23 30.6.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 728 1,763

CURRENT ASSETS
Cash at bank 36,451 57,242

CREDITORS
Amounts falling due within one year 5 22,224 43,382
NET CURRENT ASSETS 14,227 13,860
TOTAL ASSETS LESS CURRENT
LIABILITIES

14,955

15,623

CREDITORS
Amounts falling due after more than one
year

6

14,586

14,586
NET ASSETS 369 1,037

CAPITAL AND RESERVES
Called up share capital 7 2 2
Retained earnings 367 1,035
SHAREHOLDERS' FUNDS 369 1,037

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2024 and were signed on its behalf by:



Dr A Hussain - Director


Nanobiotech London Limited (Registered number: 07099361)

Notes to the Financial Statements
for the Year Ended 30 June 2023

1. STATUTORY INFORMATION

Nanobiotech London Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Fixtures and fittings - 20% on reducing balance

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and
machinery fittings Totals
£    £    £   
COST
At 1 July 2022
and 30 June 2023 5,245 1,122 6,367
DEPRECIATION
At 1 July 2022 3,582 1,022 4,604
Charge for year 935 100 1,035
At 30 June 2023 4,517 1,122 5,639
NET BOOK VALUE
At 30 June 2023 728 - 728
At 30 June 2022 1,663 100 1,763

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.23 30.6.22
£    £   
Trade creditors 1,860 3,900
Other creditors 20,364 39,482
22,224 43,382

Nanobiotech London Limited (Registered number: 07099361)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2023

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.6.23 30.6.22
£    £   
Other creditors 14,586 14,586

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.23 30.6.22
value: £    £   
2 Ordinary £1 2 2